Report cover image

InSightec Ltd - Product Pipeline Analysis, 2026 Update

Publisher GlobalData
Published Apr 20, 2026
Length 39 Pages
SKU # GBDT21121802

Description

Summary Insightec Ltd (Insightec) is a healthcare company creating the next generation of patient care by realizing the therapeutic power of focused ultrasound. The company’s Exablate Prime platform focuses sound waves, safely guided by MRI, to provide tremor treatment to patients with medication-refractory essential tremor and Parkinson’s disease. Insightec's solutions are utilized by healthcare professionals and treatment centers to offer patients an alternative to medication-refractory conditions. The company collaborates with various treatment centers and healthcare providers to distribute its technology. InSightec is headquartered in Tirat Carmel, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company InSightec Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

39 Pages
InSightec Ltd Company Overview
InSightec Ltd Company Snapshot
InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview
InSightec Ltd – Pipeline Analysis Overview
InSightec Ltd - Key Facts
InSightec Ltd - Major Products and Services
InSightec Ltd Pipeline Products by Development Stage
InSightec Ltd Ongoing Clinical Trials by Trial Status
InSightec Ltd Pipeline Products Overview
ExAblate - Brain Cancer
ExAblate - Brain Cancer Product Overview
ExAblate - Brain Cancer Clinical Trial
ExAblate - Liver Cancer
ExAblate - Liver Cancer Product Overview
ExAblate - Metastatic Breast Cancer
ExAblate - Metastatic Breast Cancer Product Overview
Exablate Neuro - Alzheimer’s Disease
Exablate Neuro - Alzheimer’s Disease Product Overview
Exablate Neuro - Alzheimer’s Disease Clinical Trial
Exablate Neuro System - NSCLC
Exablate Neuro System - NSCLC Product Overview
InSightec Ltd - Key Competitors
InSightec Ltd - Key Employees
InSightec Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
InSightec Ltd, Recent Developments
Mar 03, 2026: Insightec Announces National Reimbursement in France for Mr-Guided Focused Ultrasound to Treat Essential Tremor
Feb 05, 2026: Insightec Secures Health Canada Approval for Exablate Prime System
Oct 16, 2025: New Ultrasound Research Tool Deployed Against Alzheimer’s, Parkinson’s
Sep 16, 2025: Insightec's Incisionless Focused Ultrasound Therapy Successfully Treats Downton Abbey Creator Lord Julian Fellowes for Essential Tremor
Jul 08, 2025: Insightec Announces FDA Approval of Staged Bilateral Focused Ultrasound Treatment for Parkinson’s Disease
Feb 24, 2025: Allina Health Neuroscience, Spine and Pain Institute Launches Focused Ultrasound Program
Nov 22, 2024: EmStop completes trial of embolic protection system
Apr 16, 2024: Insightec Announces Exablate Prime Availability in Europe -The Next Generation of MR-Guided Focused Ultrasound
Mar 04, 2024: Insightec’s Groundbreaking Transcranial Mr-Guided Focused Ultrasound (MRgFUS) Approved for Additional Reimbursement for Essential Tremor in Germany
Mar 04, 2024: Insightec’s MRgFUS secures reimbursement boost in Germany
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview
InSightec Ltd Pipeline Products by Equipment Type
InSightec Ltd Pipeline Products by Indication
InSightec Ltd Ongoing Clinical Trials by Trial Status
InSightec Ltd, Key Facts
InSightec Ltd, Major Products and Services
InSightec Ltd Number of Pipeline Products by Development Stage
InSightec Ltd Pipeline Products Summary by Development Stage
InSightec Ltd Ongoing Clinical Trials by Trial Status
InSightec Ltd Ongoing Clinical Trials Summary
ExAblate - Brain Cancer - Product Status
ExAblate - Brain Cancer - Product Description
ExAblate - Brain Cancer - A Safety and Feasibility Study to Evaluate Blood Brain Barrier Disruption Using Exablate MR Guided Focused Ultrasound in Combination With Doxorubicin in Treating Pediatric Patients with Diffuse Intrinsic Pontine Gliomas (DIPG)
ExAblate - Liver Cancer - Product Status
ExAblate - Liver Cancer - Product Description
ExAblate - Metastatic Breast Cancer - Product Status
ExAblate - Metastatic Breast Cancer - Product Description
Exablate Neuro - Alzheimer’s Disease - Product Status
Exablate Neuro - Alzheimer’s Disease - Product Description
Exablate Neuro - Alzheimer’s Disease - Assessment of Safety and Efficacy of ExAblate Blood-brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer's Disease
Exablate Neuro - Alzheimer’s Disease - Early Feasibility Study of Low-Intensity Focused Ultrasound (LIFU) Neuromodulation in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Exablate Neuro System - NSCLC - Product Status
Exablate Neuro System - NSCLC - Product Description
InSightec Ltd, Key Employees
InSightec Ltd, Other Locations
Glossary
List of Figures
InSightec Ltd Pipeline Products by Equipment Type
InSightec Ltd Pipeline Products by Development Stage
InSightec Ltd Ongoing Clinical Trials by Trial Status

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.